揚宇科技(08113.HK)一季度純利大增194.70%至1350.3萬港元
格隆匯 5 月 6日丨揚宇科技(08113.HK)公吿,截至2021年3月31日止第一季度,公司實現收益7.18億港元,同比增長76.33%;公司擁有人應占溢利1350.3萬港元,同比增長194.70%;每股盈利2.07港仙。
於2021年第一季度,遠程工作及學習在冠狀病毒病疫情(COVID-19)期間蔚然成風,帶動消費電子產品的需求上升,進而推動市場對面板的需求增加。此外,材料及元件的短缺亦成為面板價格上漲的因素。集團的Innolux面板解決方案於第一季度的銷售額較去年同期顯着增長,MID分部仍是集團最大的收益分部。再者,手機由4G升級至5G對我們的智慧手機面板模組解決方案的收益大幅增長作出貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.